Literature DB >> 11731631

Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age.

D B McElhinney1, D McDonald-McGinn, E H Zackai, E Goldmuntz.   

Abstract

OBJECTIVE: Cardiovascular anomalies are present in 75% to 80% of patients with a chromosome 22q11 deletion. In the majority of cases, the cardiovascular defect becomes evident in the neonatal period and is often the initial manifestation of the chromosome 22q11 deletion syndrome. However, a 22q11 deletion may also be associated with cardiovascular defects that are less obvious, such as a vascular ring, which may not be diagnosed until the patient is older. The objective of this study was to determine the frequency and types of cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age.
METHODS: We studied 29 patients diagnosed with a chromosome 22q11 deletion at a median age of 6.2 years (9 months to 45 years) who were subsequently referred for cardiovascular evaluation. Comprehensive cardiologic evaluation was performed, with transthoracic echocardiography (N = 28) and/or magnetic resonance imaging (N = 6), including imaging of the aortic arch. The frequency of cardiovascular anomalies diagnosed in these patients and the need for intervention were assessed.
RESULTS: Cardiovascular anomalies were detected in 11 (38%) patients: 3 with a vascular ring formed by a right aortic arch with an aberrant left subclavian artery and left-sided ligamentum arteriosum, 3 with a right aortic arch with mirror-image branching of the brachiocephalic arteries (no vascular ring; 1 with a patent ductus arteriosus), 4 with a left aortic arch with an aberrant right subclavian artery (no vascular ring; 1 with a patent ductus), and 1 with a left superior vena cava draining to the coronary sinus. The median age at diagnosis in these 11 patients was 3 years (9 months to 28 years). The remaining 18 patients had normal cardiovascular anatomy. All 3 patients with vascular rings subsequently underwent surgical repair, and 1 patient with a ductus arteriosus underwent transcatheter coil occlusion.
CONCLUSIONS: The frequency of cardiovascular anomalies necessitating intervention in patients referred for cardiovascular evaluation after diagnosis of a chromosome 22q11 deletion beyond 6 months of age is 14% in our experience. Routine screening for cardiovascular anomalies, including echocardiography and other imaging studies to identify the laterality and branching pattern of the aortic arch, is indicated in patients diagnosed with 22q11 deletion beyond 6 months of age and is particularly critical for patients with respiratory or feeding disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11731631     DOI: 10.1542/peds.108.6.e104

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.

Authors:  Candice K Silversides; Marla Kiess; Luc Beauchesne; Timothy Bradley; Michael Connelly; Koichiro Niwa; Barbara Mulder; Gary Webb; Jack Colman; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

2.  Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial.

Authors:  Ronald J Wapner; Deborah A Driscoll; Joe Leigh Simpson
Journal:  Prenat Diagn       Date:  2012-04       Impact factor: 3.050

Review 3.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

4.  22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases.

Authors:  Shabnam Peyvandi; Philip J Lupo; Jennifer Garbarini; Stacy Woyciechowski; Sharon Edman; Beverly S Emanuel; Laura E Mitchell; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2013-04-21       Impact factor: 1.655

5.  Sinus of valsalva aneurysm rupture: an unusual presentation of chromosome 22q11.2 deletion: a case report.

Authors:  Eda-Cristina Abuchaibe; Nancy Dobrolet; Katherine Peicher; Roque Ventura; Elizabeth Welch
Journal:  Case Rep Pediatr       Date:  2012-09-23

6.  Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times.

Authors:  Alex Habel; Richard Herriot; Dinakantha Kumararatne; Jeremy Allgrove; Kate Baker; Helen Baxendale; Frances Bu'Lock; Helen Firth; Andrew Gennery; Anthony Holland; Claire Illingworth; Nigel Mercer; Merel Pannebakker; Andrew Parry; Anne Roberts; Beverly Tsai-Goodman
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

7.  Prevalence of associated extracardiac anomalies in prenatally diagnosed congenital heart diseases.

Authors:  Chi-Son Chang; Sir-Yeon Hong; Seo-Yeon Kim; Yoo-Min Kim; Ji-Hee Sung; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Jinyoung Song; June Huh; I-Seok Kang
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

8.  Genetic Analysis Algorithm for the Study of Patients with Multiple Congenital Anomalies and Isolated Congenital Heart Disease.

Authors:  Marisol Delea; Lucia S Massara; Lucia D Espeche; María Paz Bidondo; Pablo Barbero; Jaen Oliveri; Paloma Brun; Mónica Fabro; Micaela Galain; Cecilia S Fernández; Melisa Taboas; Carlos D Bruque; Jorge E Kolomenski; Agustín Izquierdo; Ariel Berenstein; Viviana Cosentino; Celeste Martinoli; Mariana Vilas; Mónica Rittler; Rodrigo Mendez; Lilian Furforo; Rosa Liascovich; Boris Groisman; Sandra Rozental; Liliana Dain
Journal:  Genes (Basel)       Date:  2022-06-29       Impact factor: 4.141

9.  Variety of prenatally diagnosed congenital heart disease in 22q11.2 deletion syndrome.

Authors:  Mi-Young Lee; Hye-Sung Won; Ju Won Baek; Jae-Hyun Cho; Jae-Yoon Shim; Pil-Ryang Lee; Ahm Kim
Journal:  Obstet Gynecol Sci       Date:  2014-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.